BioClinica, Inc. to Participate in Upcoming Industry Events and Demonstrate Global Technology–Enhanced Clinical Trial Management Capabilities

NEWTOWN, Pa.--(BUSINESS WIRE)-- BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and lead discussions at several upcoming industry conferences in October, November, and December. BioClinica experts will share industry trends and also demonstrate the company’s suite of eClinical Solutions and Imaging Core Lab Services. The conferences include:

Association of Clinical Research Professionals (ACRP) Research Triangle Park (RTP) Chapter

13th Annual Fall Conference

October 5 – 6, 2012

Research Triangle Park, North Carolina

The Association of Clinical Research Professionals (ACRP) is the primary resource for clinical research professionals in the pharmaceutical, biotechnology, and medical device industries, and those in hospital, academic medical centers, and physician office settings. The organization’s mission is to provide global leadership to promote integrity and excellence for the clinical research profession. The Research Triangle Park chapter will hold its 13th Annual Fall Conference at the North Carolina Biotechnology Center. Jonathan Andrus, BioClinica’s Senior Vice President of Operations, will speak on the topic, “The New eSource Draft Guidance - What Does it Mean to Me as a Site, CRA or Data Manager?”

BioClinica Annual User Conference

October 8 – 10, 2012

King of Prussia, Pennsylvania

The BioClinica User Conference is two days of valuable presentations, case studies, and discussions on ways to maximize the effectiveness of BioClinica’s eClinical Solutions. It’s an opportunity to learn the latest tips and tricks from top developers and innovators while meeting and networking with other industry professionals who utilize BioClinica technology and services to run faster, more efficient trials. This free event is conducted exclusively for BioClinica’s valued customers.

American Society for Bone and Mineral Research Annual Meeting

October 12 – 15, 2012

Minneapolis, Minnesota

The ASBMR 2012 Annual Meeting will feature state-of-the-art lectures, clinical roundtables, and plenary oral presentations from leaders in the bone and mineral field. Attendees will learn about the latest research, technology, and treatment in bone and mineral science and can take part in guided poster session tours lead by prominent scientists. BioClinica’s Senior Vice President of Medical Affairs, Colin G. Miller, Ph.D., F.I.C.R., CSci, will attend the meeting and will co-present a poster with Dr. Neil Binkley of the University of Wisconsin Osteoporosis Clinical Center and Research Program titled “Dual Energy X-ray Absorptiometry Body Composition: A New Phantom for Clinical Trials.”

ShareFEST Europe

October 18, 2012

Amsterdam, The Netherlands

Booth #4

ShareFEST is the premier SharePoint conference for life sciences. The conference brings together attendees from pharmaceutical companies, device manufacturers, biotechs, and service providers from around the world to share information about their use of SharePoint to address life sciences' business needs. This one day conference will feature case studies and best practices from leading pharmaceutical companies, as well as Microsoft executives speaking about Microsoft's plans for SharePoint. There will also be consultants and solution providers on the exhibit floor demonstrating SharePoint solutions that address life sciences' business needs. Jeremiah Rehm, BioClinica’s eClinial Solutions Specialist, will speak on the topic “Site Monitoring Made Easier.” As an event sponsor, BioClinica representatives will be on hand to demonstrate the company’s industry-leading eClinical solutions.

11th Annual Partnerships in Clinical Trials Europe Congress and Exhibition

November 7, 2012

Hamburg, Germany

Booth #808

The 11th Annual Partnerships in Clinical Trials Congress and Exhibition will feature five interactive, multi-speaker symposia as well as several tracks presenting important issues in clinical trials. As an event sponsor, BioClinica representatives will be on hand to demonstrate the company’s industry-leading eClinical solutions and Imaging Core Lab services.

2nd Annual Interactive Response Technologies for Clinical Trials Conference

November 8 – 9, 2012

Philadelphia, Pennsylvania

Interactive Response Technologies (IRT) are utilized to increase efficiencies and decrease the costs of conducting clinical trials and managing the data and investigational drug supply. Conference attendees will gain insights into IVR/IWR system utilization in clinical trials and learn how companies are using clinical IRTs to increase efficiencies and decrease costs. BioClinica Consultant Ed Tourtellotte will speak on the topic “A Sampling of Current Randomization Schemes using IRTs.” As an event sponsor, BioClinica representatives will be on hand to demonstrate the company’s industry-leading eClinical solutions.

6th Annual Alzheimer's Drug Development Summit

December 10 – 11, 2012

Philadelphia, Pennsylvania

The release of recent, high-profile clinical trial results and the turn of Alzheimer’s disease research to preventative and translational treatments are important updates towards the goal to cure Alzheimer’s disease. These approaches, along with the increasing use of biomarkers, are the driving force of new research and the development of preventing and treating Alzheimer’s disease. This summit will feature critical insights, research, and key updates from industry leaders focused on the goal of understanding past, current, and future research findings and clinical trials to continue advancing knowledge and innovation. Chahin Pachai, PhD, Vice President and Executive Director of BioClinica’s Imaging office in Lyon, France, will co-present a workshop titled “New Advancements in Imaging Technology - Alzheimer’s Clinical Trials and the Impact on Detection and Diagnosis.”

About BioClinica, Inc.

BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica solutions maximize efficiency and manageability throughout all phases of the clinical trial process. With over 20 years of experience and more than 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit

Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company’s statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the consummation and the successful integration of current and proposed acquisitions, the timing of projects due to the variability in size, scope and duration of projects, estimates and guidance made by management with respect to the Company’s financial results, backlog, critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company’s control. The factors discussed herein and expressed from time to time in the Company’s filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance. You should review the Company’s filings, especially risk factors contained in the Form 10-K and the recent Form 10-Q.

BioClinica, Inc.
Jim Dorsey, 267-757-3040
Trade Media:
Diccicco Battista Communications
Beth Nesterode, 484-342-3600
Porter, LeVay & Rose, Inc.
Michael Porter, 212-564-4700
Financial Media:
Porter, LeVay & Rose, Inc.
Bill Gordon, 212-564-4700

Source: BioClinica, Inc.